Recently, ELFBAR launched its own e-liquid brand called ELFLIQ in Italy, which is exclusively sold by their appointed distributor Set Spa. Pre-orders began on May 5th, with the first shipment scheduled for May 20th.
ELFBAR has announced on their official website that ELFLIQ is their first and only officially designated e-liquid product. It comes in 12 different flavors including apple peach and blueberry raspberry, and is designed to provide users with the classic taste of ELFBAR on an open system. The e-liquid has a 50VG/50PG ratio and comes in nicotine strengths of 10mg and 20mg.
Marcello Balestra, the representative of Spa Set, stated that ELFBAR is moving towards a more environmentally friendly direction while maintaining its original features. Additionally, it also helps consumers save money.
Elfbar's parent company, IQIYI, informed 2FIRSTS that ELFLIQ went public last year.
Further Reading:
ELFBAR has entered the French market in February and plans to sell in 4,000 retail stores.
Some products from brands such as ELFBAR and NOQO have been registered with the "Honest Label" in Russia.
Reference:
ElfLiq is the ready-to-use 10 ml liquid format for ElfBar.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
